Prabhudas Lilladher has come out with its fourth quarter (January-March’ 19) earnings estimates for the Pharma sector. The brokerage house expects Sun Pharma to report net profit at Rs. 837 crore down 36.1% year-on-year (down 32.6% quarter-on-quarter). Net Sales are expected to increase by 8.1 Y-o-Y (down 5.3% Q-o-Q) to Rs. 7,252.9 crore.